ICU Medical Q2 revenue down 8% to $549M, but GAAP net income of $35.3M vs year-ago loss

ICU MEDICAL INC/DE

2025-Q2 EPS reported $0.80 revenue$1,153,568,000

Revenue $548.9M vs $596.5M YoY; GAAP gross margin improved to 38% from 35%.
GAAP net income $35.3M ($1.43 diluted EPS) vs net loss of $(21.4M) ($(0.88) EPS) in Q2 2024.
Adjusted diluted EPS $2.10 vs $1.56 YoY; Adjusted EBITDA $100.3M vs $91.3M.
Fiscal 2025 guidance updated in the press release; specifics not provided in excerpt.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.